Mitochondrial Nutrient Combinations for Reversing Aging Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
D-galactose exposure in animals leads to aging-related issues such as shortened lifespan, cognitive dysfunction, mitochondrial dysfunction, and oxidative stress, which existing technologies have not effectively addressed.
Innovation Solution
Administration of specific combinations of mitochondria-targeting antioxidants and cofactors, including resveratrol, grape seed extract, quercetin, and other nutrients, to reverse mitochondrial dysfunction and attenuate aging-related impairments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If D-galactose is administered to induce aging model, then aging-related symptoms are produced, but mitochondrial dysfunction and oxidative stress are worsened
Solution Approach 1:
The patent uses D-galactose-induced mitochondrial dysfunction and oxidative stress as a model to screen for compounds that can reverse these effects. The harmful aging symptoms produced by D-galactose are converted into a beneficial screening tool for identifying anti-aging compounds that restore mitochondrial function and reduce oxidative damage.
Solution Approach 2:
The patent introduces mitochondrial-targeted antioxidants and cofactors as intermediary substances that mediate between the harmful D-galactose exposure and the cellular damage. These compounds act as intermediaries to neutralize ROS, support mitochondrial function, and prevent the progression of aging-related damage.
2Object-affected harmful factors
If conventional antioxidants are used, then oxidative stress is reduced, but mitochondrial function is not sufficiently restored
Solution Approach 1:
The patent employs antioxidants and cofactors that are specifically targeted to mitochondria rather than acting systemically throughout the cell. This local targeting ensures that the compounds concentrate where they are most needed - within the mitochondrial matrix and inner membrane - to directly address mitochondrial dysfunction and restore electron transport chain function.
Solution Approach 2:
The patent uses combinations of multiple mitochondrial-targeted compounds including antioxidants (such as MitoQ, SkQ1), cofactors (such as ubiquinol, PQQ), and amino acids (such as acetyl-L-carnitine). These composite formulations work synergistically to address multiple aspects of mitochondrial dysfunction simultaneously - reducing oxidative stress, supporting electron transport, and maintaining mitochondrial membrane integrity.
3Reliability
If mitochondrial nutrients are administered, then mitochondrial function is improved, but complexity of treatment increases
Solution Approach 1:
The patent combines multiple mitochondrial-supporting compounds into single composite formulations or kits. These merged formulations include combinations of antioxidants, cofactors, and amino acids that can be administered together to provide comprehensive mitochondrial support in a single treatment regimen, reducing the burden of multiple separate administrations.
Solution Approach 2:
The patent develops mitochondrial nutrient formulations that serve multiple functions simultaneously - acting as antioxidants, electron transport supporters, membrane stabilizers, and metabolic cofactors. This multi-functionality allows a single treatment composition to address various aspects of mitochondrial dysfunction without requiring separate targeted therapies for each function.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nutrient combinations effectively reverse D-gal-induced muscular impairment, restore complex I function in skeletal and heart muscles, and increase lifespan, mimicking the effects of caloric restriction.
Implementation Method 1
D-gal treated animals showed some hallmarks of aging, such as a shortened life span, cognitive dysfunction, presbycusis, increased oxidative stress, decreased antioxidant enzyme activity
Implementation Method 2
decreased antioxidant enzyme activity
Implementation Method 3
reversing complex I dysfunction in both skeletal muscle and heart muscle
Implementation Method 4
mitochondrial dysfunction, which in turn produces more ROS
Implementation Method 5
accumulation of mitochondrial DNA (mtDNA) mutations, and mitochondrial dysfunction
Data Source
AI summary
A composition comprising an effective amount of a combination of mitochondrial nutrients sufficient to affect mitochondrial function. A method of affecting an aging process in a subject comprising administering to a subject an effective amount of a combination of mitochondrial nutrients sufficient to affect an aging process. A method of identifying a combination of mitochondrial nutrients sufficient to affect an aging process in a subject, the method comprising: administering a combination of mitochondrial nutrients to a subject; and determining whether the mitochondrial nutrients affect an aging process in the subject.